Wells Fargo Maintains Overweight on Axogen, Raises Price Target to $56
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.
Wells Fargo analyst Larry Biegelsen maintains Axogen (NASDAQ:AXGN) with a Overweight and raises the price target from $48 to $56.